U.S. Markets open in 7 hrs 26 mins

Market Trends Toward New Normal in Cypress Semiconductor, OUTFRONT Media, R1 RCM, Graham, CVS Health, and Tandem Diabetes Care — Emerging Consolidated Expectations, Analyst Ratings

NEW YORK, March 01, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Cypress Semiconductor Corporation (CY), OUTFRONT Media Inc. (OUT), R1 RCM Inc. (RCM), Graham Holdings Company (GHC), CVS Health Corporation (CVS), and Tandem Diabetes Care, Inc. (TNDM), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

CY DOWNLOAD: http://Capital-Review.com/register/?so=CY
OUT DOWNLOAD: http://Capital-Review.com/register/?so=OUT
RCM DOWNLOAD: http://Capital-Review.com/register/?so=RCM
GHC DOWNLOAD: http://Capital-Review.com/register/?so=GHC
CVS DOWNLOAD: http://Capital-Review.com/register/?so=CVS
TNDM DOWNLOAD: http://Capital-Review.com/register/?so=TNDM

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Capital Review, available for free download at the links above, examine Cypress Semiconductor Corporation (CY), OUTFRONT Media Inc. (OUT), R1 RCM Inc. (RCM), Graham Holdings Company (GHC), CVS Health Corporation (CVS), and Tandem Diabetes Care, Inc. (TNDM) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 27th, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

CYPRESS SEMICONDUCTOR CORPORATION (CY) REPORT OVERVIEW

Cypress Semiconductor's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Cypress Semiconductor reported revenue of $604.47MM vs $597.55MM (up 1.16%) and analysts estimated basic earnings per share $0.74 vs -$0.10. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Cypress Semiconductor reported revenue of $2,483.84MM vs $2,327.77MM (up 6.70%) and analysts estimated basic earnings per share $0.99 vs -$0.24. Analysts expect earnings to be released on April 25th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.23. The estimated EPS forecast for the next fiscal year is $1.04 and is expected to report on January 30th, 2020.

To read the full Cypress Semiconductor Corporation (CY) report, download it here: http://Capital-Review.com/register/?so=CY

-----------------------------------------

OUTFRONT MEDIA INC. (OUT) REPORT OVERVIEW

OUTFRONT Media's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, OUTFRONT Media reported revenue of $414.20MM vs $392.40MM (up 5.56%) and analysts estimated basic earnings per share $0.33 vs $0.36 (down 8.33%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, OUTFRONT Media reported revenue of $1,520.50MM vs $1,513.90MM (up 0.44%) and analysts estimated basic earnings per share $0.90 vs $0.66 (up 36.36%). Analysts expect earnings to be released on May 1st, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.27. The estimated EPS forecast for the next fiscal year is $2.31 and is expected to report on February 25th, 2020.

To read the full OUTFRONT Media Inc. (OUT) report, download it here: http://Capital-Review.com/register/?so=OUT

-----------------------------------------

R1 RCM INC. (RCM) REPORT OVERVIEW

R1 RCM's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, R1 RCM reported revenue of $250.40MM vs $123.20MM (up 103.25%) and analysts estimated basic earnings per share -$0.17 vs -$0.08. For the twelve months ended December 31st, 2017 vs December 31st, 2016, R1 RCM reported revenue of $449.80MM vs $592.60MM (down 24.10%) and analysts estimated basic earnings per share -$0.75 vs $0.65. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.14. The estimated EPS forecast for the next fiscal year is $0.34 and is expected to report on February 28th, 2020.

To read the full R1 RCM Inc. (RCM) report, download it here: http://Capital-Review.com/register/?so=RCM

-----------------------------------------

GRAHAM HOLDINGS COMPANY (GHC) REPORT OVERVIEW

Graham's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Graham reported revenue of $674.77MM vs $657.23MM (up 2.67%) and basic earnings per share $23.43 vs $4.45 (up 426.52%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Graham reported revenue of $2,591.85MM vs $2,481.89MM (up 4.43%) and analysts estimated basic earnings per share $54.24 vs $29.95 (up 81.10%). Analysts expect earnings to be released on May 1st, 2019. The report will be for the fiscal period ending March 31st, 2019.

To read the full Graham Holdings Company (GHC) report, download it here: http://Capital-Review.com/register/?so=GHC

-----------------------------------------

CVS HEALTH CORPORATION (CVS) REPORT OVERVIEW

CVS Health's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, CVS Health reported revenue of $54,424.00MM vs $48,385.00MM (up 12.48%) and analysts estimated basic earnings per share -$0.37 vs $3.22. For the twelve months ended December 31st, 2018 vs December 31st, 2017, CVS Health reported revenue of $194,579.00MM vs $184,765.00MM (up 5.31%) and analysts estimated basic earnings per share -$0.57 vs $6.47. Analysts expect earnings to be released on May 1st, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $1.48. The estimated EPS forecast for the next fiscal year is $7.70 and is expected to report on February 19th, 2020.

To read the full CVS Health Corporation (CVS) report, download it here: http://Capital-Review.com/register/?so=CVS

-----------------------------------------

TANDEM DIABETES CARE, INC. (TNDM) REPORT OVERVIEW

Tandem Diabetes Care's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Tandem Diabetes Care reported revenue of $46.26MM vs $27.00MM (up 71.33%) and analysts estimated basic earnings per share -$0.62 vs -$3.09. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Tandem Diabetes Care reported revenue of $107.60MM vs $84.25MM (up 27.72%) and analysts estimated basic earnings per share -$12.87 vs -$27.30. Analysts expect earnings to be released on April 25th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$1.03. The estimated EPS forecast for the next fiscal year is -$0.48 and is expected to report on February 25th, 2020.

To read the full Tandem Diabetes Care, Inc. (TNDM) report, download it here: http://Capital-Review.com/register/?so=TNDM

-----------------------------------------

ABOUT CAPITAL REVIEW

Capital Review is a nationally recognized publisher of financial analysis, research reports, and exclusive market reporting. Institutional investors, registered brokers, professional traders, and personal investment advisers rely on Capital Review to quantify public company valuations, discover opportunity across asset classes, stay informed about market-moving events, and read exclusive analysis of important material developments. With 14 offices worldwide, Capital Review staffs and manages certified and registered financial professionals, including Chartered Financial Analyst® (CFA®) designation holders and FINRA® BrokerCheck® certified individuals with current and valid CRD® number designations, to enable continuous coverage of topics relevant to its regular active reader base.

REGISTERED MEMBER STATUS

Capital Review's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Capital Review's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Capital Review have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Capital Review's Compliance department by Phone, at +1 (410) 280-7496, or by E-mail at compliance@Capital-Review.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Capital Review, Capital Review members, and/or Capital Review affiliates are not responsible for any gains or losses that result from the opinions expressed. Capital Review makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Capital Review has not been compensated for the publication of this press release by any of the above mentioned companies. Capital Review is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Nicole Garrens, Media Department
Office: +1 (410) 280-7496
E-mail: media@Capital-Review.com

© 2019 Capital Review. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Capital-Review.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.